{"id":"https://openalex.org/W2914587352","doi":"https://doi.org/10.1111/bjh.15790","title":"Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10\u2010year pharmacovigilance analysis","display_name":"Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10\u2010year pharmacovigilance analysis","alternate_titles":[],"publication_year":2019,"publication_date":"2019-02-15","ids":{"openalex":"https://openalex.org/W2914587352","doi":"https://doi.org/10.1111/bjh.15790","mag":"2914587352","pmid":"https://pubmed.ncbi.nlm.nih.gov/30768680","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6594003"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.15790","doi":"https://doi.org/10.1111/bjh.15790","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.15790","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.15790","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2914587352"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.15790","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012691135","display_name":"G\u00e8rard Soci\u00e9","orcid":"https://orcid.org/0000-0002-2114-7533","observed_orcids":["https://orcid.org/0000-0002-2114-7533"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"G\u00e9rard Soci\u00e9","raw_affiliation_strings":["Hematology/Transplantation, APHP Hospital Saint Louis, University Paris VII, Paris, France"],"raw_orcid":"https://orcid.org/0000-0002-2114-7533","affiliations":[{"raw_affiliation_string":"Hematology/Transplantation, APHP Hospital Saint Louis, University Paris VII, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210144610","https://openalex.org/I4387154366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042001439","display_name":"Marie\u2010Pierre Caby\u2010Tosi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie\u2010Pierre Caby\u2010Tosi","raw_affiliation_strings":["Alexion Europe SAS, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexion Europe SAS, Rueil-Malmaison, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062685257","display_name":"Jing L. Marantz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125492","display_name":"Alexion Pharmaceuticals (United States)","ror":"https://ror.org/031ywxc85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210125492"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jing L. Marantz","raw_affiliation_strings":["Alexion Pharmaceuticals, Inc., Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexion Pharmaceuticals, Inc., Lexington, MA, USA","institution_ids":["https://openalex.org/I4210125492"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alexander Cole","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125492","display_name":"Alexion Pharmaceuticals (United States)","ror":"https://ror.org/031ywxc85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210125492"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexander Cole","raw_affiliation_strings":["Alexion Pharmaceuticals, Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexion Pharmaceuticals, Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I4210125492"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030996416","display_name":"Camille L. Bedrosian","orcid":"https://orcid.org/0009-0005-9213-4982","observed_orcids":["https://orcid.org/0009-0005-9213-4982"]},"institutions":[{"id":"https://openalex.org/I4210125492","display_name":"Alexion Pharmaceuticals (United States)","ror":"https://ror.org/031ywxc85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210125492"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Camille L. Bedrosian","raw_affiliation_strings":["Alexion Pharmaceuticals, Inc., New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexion Pharmaceuticals, Inc., New Haven, CT, USA","institution_ids":["https://openalex.org/I4210125492"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052896342","display_name":"Christoph Gasteyger","orcid":"https://orcid.org/0009-0002-6730-0385","observed_orcids":["https://orcid.org/0009-0002-6730-0385"]},"institutions":[{"id":"https://openalex.org/I49313256","display_name":"Alexion Pharma (Switzerland)","ror":"https://ror.org/05hkjyh45","country_code":"CH","type":"company","lineage":["https://openalex.org/I49313256"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christoph Gasteyger","raw_affiliation_strings":["Alexion Pharma GmbH Z\u00fcrich Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexion Pharma GmbH Z\u00fcrich Switzerland","institution_ids":["https://openalex.org/I49313256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001900852","display_name":"Arshad Mujeebuddin","orcid":"https://orcid.org/0000-0002-4752-7016","observed_orcids":["https://orcid.org/0000-0002-4752-7016"]},"institutions":[{"id":"https://openalex.org/I4210125492","display_name":"Alexion Pharmaceuticals (United States)","ror":"https://ror.org/031ywxc85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210125492"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arshad Mujeebuddin","raw_affiliation_strings":["Alexion Pharmaceuticals, Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexion Pharmaceuticals, Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I4210125492"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047631289","display_name":"Peter Hillmen","orcid":"https://orcid.org/0000-0001-5617-4403","observed_orcids":["https://orcid.org/0000-0001-5617-4403"]},"institutions":[{"id":"https://openalex.org/I2801331674","display_name":"St James's University Hospital","ror":"https://ror.org/013s89d74","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153","https://openalex.org/I2801331674"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Hillmen","raw_affiliation_strings":["St James's University Hospital, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St James's University Hospital, Leeds, UK","institution_ids":["https://openalex.org/I2801331674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061152501","display_name":"Johan Vande Walle","orcid":"https://orcid.org/0000-0001-9700-5358","observed_orcids":["https://orcid.org/0000-0001-9700-5358"]},"institutions":[{"id":"https://openalex.org/I2801227569","display_name":"Ghent University Hospital","ror":"https://ror.org/00xmkp704","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801227569"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Johan Vande Walle","raw_affiliation_strings":["University Hospital Ghent, Ghent, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Ghent, Ghent, Belgium","institution_ids":["https://openalex.org/I2801227569"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110143117","display_name":"Hermann G. Haller","orcid":"https://orcid.org/0000-0002-8361-6446","observed_orcids":["https://orcid.org/0000-0002-8361-6446","https://orcid.org/0009-0000-5740-838X"]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hermann Haller","raw_affiliation_strings":["Hannover Medical School, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hannover Medical School, Hannover, Germany","institution_ids":["https://openalex.org/I34809795"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5012691135"],"corresponding_institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210144610","https://openalex.org/I4387154366"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":{"value":3500,"currency":"USD","value_usd":3500},"fwci":10.3505,"has_fulltext":true,"cited_by_count":259,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.99122704,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"185","issue":"2","first_page":"297","last_page":"310"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eculizumab","display_name":"eculizumab","score":1.0},{"id":"https://openalex.org/keywords/paroxysmal-nocturnal-hemoglobinuria","display_name":"paroxysmal nocturnal hemoglobinuria","score":0.9980000257492065},{"id":"https://openalex.org/keywords/atypical-hemolytic-uremic-syndrome","display_name":"atypical hemolytic uremic syndrome","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8730000257492065},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7770000100135803},{"id":"https://openalex.org/keywords/meningococcal-disease","display_name":"meningococcal disease","score":0.9739999771118164},{"id":"https://openalex.org/keywords/neisseria-infections","display_name":"Neisseria infections","score":0.8830000162124634},{"id":"https://openalex.org/keywords/pneumonia","display_name":"pneumonia","score":0.5400000214576721},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.6869999766349792},{"id":"https://openalex.org/keywords/pregnancy-outcomes","display_name":"pregnancy outcomes","score":0.5419999957084656},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7789999842643738},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.9570000171661377},{"id":"https://openalex.org/keywords/risk-reduction","display_name":"risk mitigation","score":0.6610000133514404}],"concepts":[{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.9838317632675171},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8449152708053589},{"id":"https://openalex.org/C2778384902","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Sepsis","level":2,"score":0.5685274004936218},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5566858053207397},{"id":"https://openalex.org/C2777346216","wikidata":"https://www.wikidata.org/wiki/Q1479494","display_name":"Paroxysmal nocturnal hemoglobinuria","level":2,"score":0.4744085967540741},{"id":"https://openalex.org/C2777628635","wikidata":"https://www.wikidata.org/wiki/Q1765564","display_name":"Septic shock","level":3,"score":0.4646531939506531},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.45150506496429443},{"id":"https://openalex.org/C2778458888","wikidata":"https://www.wikidata.org/wiki/Q154625","display_name":"Neisseria meningitidis","level":3,"score":0.4270268380641937},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.41111502051353455},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31227558851242065},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.21899428963661194},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.11339199542999268},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006454","descriptor_name":"Hemoglobins","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":false},{"descriptor_ui":"D006457","descriptor_name":"Hemoglobinuria, Paroxysmal","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007231","descriptor_name":"Infant, Newborn","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008589","descriptor_name":"Meningococcal Infections","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011247","descriptor_name":"Pregnancy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011248","descriptor_name":"Pregnancy Complications","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011256","descriptor_name":"Pregnancy Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051056","descriptor_name":"Complement Inactivating Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D051056","descriptor_name":"Complement Inactivating Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060735","descriptor_name":"Pharmacovigilance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D065766","descriptor_name":"Atypical Hemolytic Uremic Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1111/bjh.15790","doi":"https://doi.org/10.1111/bjh.15790","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.15790","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.15790","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmh:oai:archive.ugent.be:8643652","doi":null,"is_oa":true,"landing_page_url":"https://biblio.ugent.be/publication/8643652","pdf_url":"https://biblio.ugent.be/publication/8643652/file/8662628.pdf","source":{"id":"https://openalex.org/S4306400478","display_name":"Ghent University Academic Bibliography (Ghent University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32597200","host_organization_name":"Ghent University","host_organization_lineage":["https://openalex.org/I32597200"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISSN: 1365-2141","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6594003","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6594003/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Haematol","raw_type":"Text"},{"id":"pmid:30768680","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30768680","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.whiterose.ac.uk:145553","doi":null,"is_oa":true,"landing_page_url":"http://eprints.whiterose.ac.uk/145553/1/Socie_Eculizuamab_10%20Year%20PV%20analysis_Br.%20J%20Haematol.2019.pdf","pdf_url":"http://eprints.whiterose.ac.uk/145553/1/Socie_Eculizuamab_10%20Year%20PV%20analysis_Br.%20J%20Haematol.2019.pdf","source":{"id":"https://openalex.org/S4306400854","display_name":"White Rose Research Online (University of Leeds, The University of Sheffield, University of York)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800616092","host_organization_name":"White Rose University Consortium","host_organization_lineage":["https://openalex.org/I2800616092"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1111/bjh.15790","doi":"https://doi.org/10.1111/bjh.15790","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.15790","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.15790","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309052","display_name":"Alexion Pharmaceuticals","ror":"https://ror.org/031ywxc85"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2914587352.pdf","grobid_xml":"https://content.openalex.org/works/W2914587352.grobid-xml"},"referenced_works_count":65,"referenced_works":["https://openalex.org/W1557532207","https://openalex.org/W1966134646","https://openalex.org/W1968469398","https://openalex.org/W1978700432","https://openalex.org/W1985521042","https://openalex.org/W1986643759","https://openalex.org/W1990431733","https://openalex.org/W1998319221","https://openalex.org/W2004265876","https://openalex.org/W2010259906","https://openalex.org/W2016750175","https://openalex.org/W2017235356","https://openalex.org/W2023377972","https://openalex.org/W2034286783","https://openalex.org/W2046048240","https://openalex.org/W2052435715","https://openalex.org/W2058082996","https://openalex.org/W2065033987","https://openalex.org/W2072874604","https://openalex.org/W2087310022","https://openalex.org/W2090669293","https://openalex.org/W2095520338","https://openalex.org/W2102537411","https://openalex.org/W2106675927","https://openalex.org/W2118510193","https://openalex.org/W2121920823","https://openalex.org/W2123753762","https://openalex.org/W2125334938","https://openalex.org/W2126092981","https://openalex.org/W2129114958","https://openalex.org/W2130696459","https://openalex.org/W2138062831","https://openalex.org/W2142968294","https://openalex.org/W2158153997","https://openalex.org/W2159884188","https://openalex.org/W2171068466","https://openalex.org/W2176787024","https://openalex.org/W2209557348","https://openalex.org/W2264090971","https://openalex.org/W2267134012","https://openalex.org/W2305176160","https://openalex.org/W2314509929","https://openalex.org/W2317757956","https://openalex.org/W2319873259","https://openalex.org/W2335653426","https://openalex.org/W2342316997","https://openalex.org/W2463102770","https://openalex.org/W2512411157","https://openalex.org/W2563850675","https://openalex.org/W2566392458","https://openalex.org/W2575318230","https://openalex.org/W2586154202","https://openalex.org/W2587527433","https://openalex.org/W2590258299","https://openalex.org/W2608364534","https://openalex.org/W2623395391","https://openalex.org/W2705109811","https://openalex.org/W2730107276","https://openalex.org/W2752157314","https://openalex.org/W2754122438","https://openalex.org/W2765259962","https://openalex.org/W2795418090","https://openalex.org/W2970919643","https://openalex.org/W4211241161","https://openalex.org/W4244301816"],"related_works":["https://openalex.org/W4385380071","https://openalex.org/W2986030647","https://openalex.org/W2493998604","https://openalex.org/W4211172913","https://openalex.org/W2026850947","https://openalex.org/W3100556461","https://openalex.org/W2582849320","https://openalex.org/W2550012861","https://openalex.org/W4399095589"],"abstract_inverted_index":{"Eculizumab":[0],"is":[1,27],"the":[2,85,173],"first":[3],"and":[4,13,37,115,126,159,181,194],"only":[5],"medication":[6],"approved":[7],"for":[8,154],"paroxysmal":[9],"nocturnal":[10],"haemoglobinuria":[11],"(PNH)":[12],"atypical":[14],"haemolytic":[15],"uraemic":[16],"syndrome":[17],"(aHUS)":[18],"treatment.":[19],"However,":[20],"eculizumab":[21,51,136,174],"safety":[22,32,170],"based":[23],"on":[24],"long-term":[25],"pharmacovigilance":[26],"unknown.":[28],"This":[29],"analysis":[30],"summarises":[31],"data":[33],"collected":[34],"from":[35,40],"spontaneous":[36],"solicited":[38],"sources":[39],"16":[41],"March":[42],"2007":[43],"through":[44],"1":[45],"October":[46],"2016.":[47],"Cumulative":[48],"exposure":[49,137],"to":[50,81,189],"was":[52],"28":[53],"518":[54],"patient-years":[55],"(PY)":[56],"(PNH,":[57],"21":[58],"016":[59],"PY;":[60],"aHUS,":[61],"7502":[62],"PY).":[63,79],"Seventy-six":[64],"cases":[65,77,134,143],"of":[66,135,141,183,192],"meningococcal":[67,82,93,193],"infection":[68,94,121,124,128],"were":[69,110,131,177],"reported":[70,106,133],"(0\u00b725/100":[71],"PY),":[72],"including":[73],"eight":[74],"fatal":[75],"PNH":[76],"(0\u00b703/100":[78],"Susceptibility":[80],"infections":[83,109,197],"remained":[84,101,164],"key":[86],"risk":[87,184,191],"in":[88,138,149,198],"patients":[89,199],"receiving":[90,200],"eculizumab.":[91,201],"The":[92,103],"rate":[95],"decreased":[96],"over":[97,166],"time;":[98],"related":[99],"mortality":[100],"steady.":[102],"most":[104],"commonly":[105],"serious":[107],"nonmeningococcal":[108],"pneumonia":[111],"(11\u00b78%);":[112],"bacteraemia,":[113],"sepsis":[114],"septic":[116],"shock":[117],"(11\u00b71%);":[118],"urinary":[119],"tract":[120],"(4\u00b71%);":[122],"staphylococcal":[123],"(2\u00b76%);":[125],"viral":[127],"(2\u00b75%).":[129],"There":[130],"434":[132],"pregnant":[139],"women;":[140],"260":[142],"with":[144],"known":[145],"outcomes,":[146],"70%":[147],"resulted":[148],"live":[150],"births.":[151],"Reporting":[152],"rates":[153],"solid":[155],"tumours":[156],"(\u22480\u00b76/100":[157],"PY)":[158,163],"haematological":[160],"malignancies":[161],"(\u22480\u00b774/100":[162],"stable":[165],"time.":[167],"No":[168],"new":[169],"signals":[171],"affecting":[172],"benefit-risk":[175],"profile":[176],"identified.":[178],"Continued":[179],"awareness":[180],"implementation":[182],"mitigation":[185],"protocols":[186],"are":[187],"essential":[188],"minimise":[190],"other":[195],"Neisseria":[196]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2914587352","counts_by_year":[{"year":2026,"cited_by_count":25},{"year":2025,"cited_by_count":44},{"year":2024,"cited_by_count":34},{"year":2023,"cited_by_count":38},{"year":2022,"cited_by_count":32},{"year":2021,"cited_by_count":37},{"year":2020,"cited_by_count":40},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-02-21T00:00:00"}
